Key pointsIn transcatheter aortic valve implantation (TAVI) subset, previous randomized controlled trials reported increased mortality when anticoagulant therapy was used in subjects without a previous oral anticoagulation (OAC) indication.The current meta-analysis confirms the worse clinical outcomes in anticoagulated patients as compared to subjects treated with antiplatelet, tough less subclinical valve thrombosis was found in the OAC group.At present, antiplatelet therapy (especially SAPT) seems the most reasonable approach in TAVI patients without indications for chronic OAC.center dot center dot
Antithrombotic therapy after TAVI: Better alone than with a bad company
Tarantini, Giuseppe;Cardaioli, Francesco
2023
Abstract
Key pointsIn transcatheter aortic valve implantation (TAVI) subset, previous randomized controlled trials reported increased mortality when anticoagulant therapy was used in subjects without a previous oral anticoagulation (OAC) indication.The current meta-analysis confirms the worse clinical outcomes in anticoagulated patients as compared to subjects treated with antiplatelet, tough less subclinical valve thrombosis was found in the OAC group.At present, antiplatelet therapy (especially SAPT) seems the most reasonable approach in TAVI patients without indications for chronic OAC.center dot center dotFile in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Cathet Cardio Intervent - 2023 - Tarantini - Antithrombotic therapy after TAVI Better alone than with a bad company.pdf
accesso aperto
Tipologia:
Published (Publisher's Version of Record)
Licenza:
Creative commons
Dimensione
78.02 kB
Formato
Adobe PDF
|
78.02 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.